Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 25 for query «psoriasis»

18 September, 2018 2:20 PM Almirall gets European Commission approval for psoriasis drug

Sun Pharma said Spanish firm Almirall has received approval from the European Commission (EC) for Ilumetri, a drug used for treating psoriasis. In July 2016, Sun Pharma out-licensed Ilumetri (tildrakizumab) to Almirall, for the development and commercialisation of the product in Europe. "As indicated by Almirall, rollout of Ilumetri in Europe will start 68

27 July, 2018 7:29 AM Lupin launches plaque psoriasis treatment spray in US market

Drug major Lupin today announced the launch of Desoximetasone Topical Spray, used for treatment of plaque psoriasis, in the US market. "Lupin's Desoximetasone Topical Spray, 0.25 percent, is the generic equivalent of Taro Pharmaceuticals USA Inc.'s Topicort Topical Spray, 0.25 percent. It is a corticosteroid indicated for the treatment of plaque psoriasis 42

28 June, 2018 9:50 AM Mylan to commercialise Lupin's etanercept biosimilar

The introduction of biosimilars is an important mechanism to help increase access to more affordable biologics treatments. Drug firms Mylan and Lupin will join hands to commercialise Lupin's biosimilar etanercept indicated for treating certain autoimmune diseases. As per the tie-up agreement, US-based Mylan will commercialise Lupin's proposed etanercept 52

20 May, 2018 6:03 AM Use Castor Oil As The Perfect Home Remedy For This Skin Disease

Castor oil for psoriasis: Psoriasis is known to be one of the most chronic and inflammatory skin diseases. Castor oil can be an effective home remedy for dealing with psoriasis. Psoriasis, an autoimmune skin disease which causes lesions and skin irritation can be treated with the help of castor oil. Psoriasis is known to be one of the most chronic and inflammatory 429

29 December, 2017 4:05 AM Lupin rises 2% on USFDA approval for Calcipotriene Topical Solution

Shares of Lupin gained 2 percent in the early trade on Friday as it has received final approval from USFDA for Calcipotriene Topical Solution. The company has received final approval for its Calcipotriene Topical Solution, 0.005% (Scalp Solution) from the United States Food and Drug Administration (USFDA) to market a generic version of Dovonex Scalp 61

22 August, 2017 3:45 PM DRL out-licenses drug to U.S.-based Encore

Pharma major Dr. Reddy’s Laboratories Ltd has out-licensed the future development, manufacturing, and commercialisation rights of DFD-06, a topical high potency steroid, to Encore Dermatology Inc. The drug is intended to be used for treatment of moderate to plaque psoriasis. Dr. Reddy’s on Tuesday said under the agreement, Encore will be responsible 65

5 May, 2016 5:03 AM Psoriasis drug to boost income, revenue in FY19-20: Analyst

Sun Pharma has completed a 12 weeks trail of its psoriasis drug, MK 3222, but needs 52-124 weeks data to apply for a license with the US FDA, says Surajit Pal, pharma analyst at Prabhudas Liladhar. Sun Pharma on Thursday said it has successfully completed three clinical trials for its psoriasis drug, MK 3222. The company has completed a 12 weeks trail 33

28 March, 2016 1:17 PM Sun Pharma may face competition from Eli Lilly’s psoriasis drug

Eli Lilly has received USFDA nod for Taltz injection, to treat plaque psoriasis, which could pose as a competition to Sun Pharma's skin disease drug. Sun Pharma was down in trade on Monday because of likely fresh competition for its skin disease drug. Eli Lilly has received US Food and Drug Administration (FDA) nod for Taltz injection to treat plaque 197

21 July, 2015 2:59 AM Sun Pharma plummets 15% after FY16 warning spurs downgrades

Shares of the country's largest pharmaceuticals firm by sales and market capitalization, Sun Pharma , fell about 15 percent in early trade Tuesday as analysts rushed to temper down their earnings expectations from the company after it warned last night its profit and revenue growth this year may be lower than estimates. The Dilip Shanghvi-run company 38

4 May, 2015 8:21 AM Glenmark up 2.5% on tentative USFDA nod for psoriasis cream

Shares of Glenmark Pharma climbed 2.55 percent intraday Monday on getting tentative approval from the US health regulator for generic Calcipotriene cream. Glenmark Pharmaceuticals Inc, USA, a subsidiary of the company, has been granted tentative approval by the United States Food and Drug Administration (USFDA) for Calcipotriene cream, 0.005 percent 22